List of bibliographic references
Number of relevant bibliographic references: 24.
[0-20] [
0 - 20][
0 - 24][
20-23][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000239 (2012) |
Shengyan Liu [Canada] ; Lyndon Jones [Canada] ; Frank X. Gu [Canada] | Nanomaterials for Ocular Drug Delivery |
| 000474 (2011) |
Sheng Chen [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada] | Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia |
| 000493 (2010) |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew J. Lees [Royaume-Uni] | Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward |
| 000584 (2010) |
Szu-Chia Lai ; Shih-Ming Jung [Taïwan] ; Padraic Grattan-Smith [Australie] ; Ella Sugo [Australie] ; Yen-Wen Lin [Taïwan] ; Rou-Shayn Chen ; Chiung-Chu Chen ; Yah-Huei Wu-Chou [Taïwan] ; Anthony E. Lang [Canada] ; Chin-Song Lu [République populaire de Chine] | Neuronal intranuclear inclusion disease: Two cases of dopa‐responsive juvenile parkinsonism with drug‐induced dyskinesia |
| 000626 (2010) |
Amitabh Gupta [Canada] ; Anthony E. Lang [Canada] | Drug‐induced cranial myoclonus |
| 000961 (2008) |
Christopher Armstrongesther [Canada] ; Brad Hagen [Canada] ; Christine Smith [Royaume-Uni] ; Sherrill Snelgrove [Royaume-Uni] | An exploratory study of nurses' knowledge of antipsychotic drug use with older persons |
| 000C12 (2006) |
John P. Etminan [Canada] ; John P. Gill [Canada] ; John P. Fitzgerald [Canada] ; John P. Samii [États-Unis] | Challenges and Opportunities for Pharmacoepidemiology in Drug‐Therapy Decision Making |
| 000D10 (2005) |
Philip E. Lee [Canada] ; Kathy Sykora [Canada] ; Sudeep S. Gill [Canada] ; Muhammad Mamdani [Canada] ; C. Marras [Canada] ; Geoff Anderson [Canada] ; Ken I. Shulman [Canada] ; Thérèse Stukel [Canada] ; Sharon-Lise Normand [Canada] ; Paula A. Rochon [Canada] | Antipsychotic Medications and Drug‐Induced Movement Disorders Other Than Parkinsonism: A Population‐Based Cohort Study in Older Adults |
| 001033 (2001) |
Yilong Xue [République populaire de Chine] ; Junmao Gao [République populaire de Chine] ; Zengfei Xi [République populaire de Chine] ; Zhenfu Wang [République populaire de Chine] ; Xinjian Li [République populaire de Chine] ; Xin Cui [République populaire de Chine] ; Yun Luo [République populaire de Chine] ; Chonghui Li [République populaire de Chine] ; Luning Wang [République populaire de Chine] ; David Zhou ; Richard Sun ; Anthony M. Sun | Microencapsulated Bovine Chromaffin Cell Xenografts into Hemiparkinsonian Rats: A Drug‐Induced Rotational Behavior and Histological Changes Analysis |
| 001082 (2001) |
Patricia Di Ciano [Royaume-Uni] ; Charles D. Blaha [Royaume-Uni] ; Anthony G. Phillips [Royaume-Uni, Canada] | Changes in dopamine efflux associated with extinction, CS-induced and d -amphetamine-induced reinstatement of drug-seeking behavior by rats |
| 001093 (2001) |
Kenneth W. Renton [Canada] | Alteration of drug biotransformation and elimination during infection and inflammation |
| 001152 (2000) |
Marise B. Parent [Canada] ; Marie K. Habib [Canada] ; Glen B. Baker [Canada] | Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine |
| 001182 (2000) |
S. Jeffrey Dixon [Canada] ; Stephen M. Sims [Canada] | P2 purinergic receptors on osteoblasts and osteoclasts: Potential targets for drug development |
| 001253 (2000) |
Tip W. Loo [Canada] ; David M. Clarke [Canada] | Blockage of Drug Resistance In Vitro by Disulfiram, a Drug Used to Treat Alcoholism |
| 001504 (1998) |
Ali Samii [Canada] ; Shallen R. Letwin [Canada] ; Donald B. Calne [Canada] | Prospects for new drug treatment in idiopathic parkinsonism |
| 001545 (1998) |
Barbara Papadopoulou [Canada] ; Christoph Kündig [Canada] ; Ajay Singh [Canada] ; Marc Ouellette [Canada] | Drug resistance in Leishmania : similarities and differences to other organisms |
| 001690 (1997) |
Nicole Mittmann [Canada] ; Barbara A. Liu [Canada] ; Michael Iskedjian [Canada] ; Carole A. Bradley [Canada] ; Robert Pless [Canada] ; Neil H. Shear [Canada] ; Thomas R. Einarson [Canada] | Drug‐Related Mortality in Canada (1984–1994) |
| 001706 (1997) |
Robert K. Drobitch [Canada] ; Roman A. Mclellan [Canada, Suède] ; Kenneth W. Renton [Canada] | Amlodipine inhibits rat microsomal cytochrome P450‐mediated drug biotransformation |
| 001866 (1996) |
P. J. Blanchet [Canada] ; R. Grondin [Canada] ; R. Bédard [Canada] | Dyskinesia and wearing‐off following dopamine D1 agonist treatment in drug‐naive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned primates |
| 001879 (1996) |
R. Grondin [Canada] ; M. Goulet [Canada] ; T. Di Paolo [Canada] ; P. J. Bédard [Canada] | Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates |
| 002400 (1987) |
Martin Fromer [Canada] ; Mohammad Shenasa [Canada] | A critical reappraisal of serial electrophysiologic drug testing for sustained ventricular tachycardia |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "drug"
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i \
-Sk "drug" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Checkpoint
|type= indexItem
|index= Title.i
|clé= drug
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
